Position in SRRK
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$5,530,549
+$735,090 QoQ
Shares Held
112,501
+3.3% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 25.17933173927343.ToString("F0")%
Shared 0.ToString("F0")%
None 74.82066826072658.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,828,718 across 284 Biotechnology names. SRRK ranks #39 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in SRRK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,530,549 | 112,501 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,795,459 | 108,864 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,608,934 | 123,763 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,440,995 | 125,381 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,882,176 | 120,752 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $4,895,140 | 113,261 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $801,112 | 100,014 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $843,645 | 101,278 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,670,434 | 94,056 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,687,300 | 89,750 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $451,474 | 63,588 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $304,540 | 40,390 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $379,030 | 29,405 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $682,777 | 27,487 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $936,150 | 28,351 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $783,421 | 27,108 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,297,149 | 25,605 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,318,754 | 27,174 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $396,892 | 22,436 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $480,215 | 26,371 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $249,780 | 20,626 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||